188
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Silymarin inhibits the lipogenic pathway and reduces worsening of non-alcoholic fatty liver disease (NAFLD) in mice

ORCID Icon, , , , , , , , , , & show all
Received 18 May 2022, Accepted 08 Sep 2022, Published online: 03 Nov 2022

References

  • Abu-Elheiga, L., et al., 2001. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-coa carboxylase 2. Science (New York, N.Y.), 291 (5513), 2613–2616.
  • Aebi, H., 1984. [13] Catalase in vitro. Methods in enzymology, 105 (C), 121–126.
  • Aharoni-Simon, M., et al., 2011. Fatty liver is associated with impaired activity of PPARγ-coactivator 1α (PGC1α) and mitochondrial biogenesis in mice. Laboratory investigation; a journal of technical methods and pathology, 91 (7), 1018–1028.
  • Araujo, C.M., et al., 2015. Morus nigra leaf extract improves glycemic response and redox profile in the liver of diabetic rats. Food & function, 6 (11), 3490–3499.
  • Aydin, G., et al., 2003. Histopathologic changes in liver and renal tissues induced by different doses of diclofenac sodium in rats. Turkish journal of veterinary and animal sciences, 27 (5), 1131–1140.
  • Barry, C. H., and Gutteridge, J. M., 1999. Free radicals in biology and medicine. Oxford: Clarendon Press.
  • Basciano, H., Federico, L., and Adeli, K., 2005. Fructose, insulin resistance, and metabolic dyslipidemia. Nutrition & metabolism, 2 (1), 5–14.
  • Bergheim, I., et al., 2008. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. Journal of hepatology, 48 (6), 983–992.
  • Buege, J.A., and Aust, S.D. 1975. “Microsomal lipid peroxidation,” Methods in enzymology.” Journal of Physics: Conference Series 71(May), 012004. http://stacks.iop.org/1742-6596/71/i=1/a=012004?key=crossref.9538450afe63dad1c84f8f585373a48b.
  • Bonoli, S.M., et al., 2004. Antioxidant phenols in barley (Hordeum vulgare L.) flour : comparative spectrophotometric study among extraction methods of free and bound phenolic compounds. Journal of agricultural and food chemistry, 52, 5195–5200.
  • Borenfreund, E., and Babich, H., 1987. In vitro cytotoxicity of heavy metals, acrylamide, and organotin salts to neural cells and fibroblasts. Cell biology and toxicology, 3 (1), 63–73.
  • Miller, B., and Janette, C., 1994. Importance of glycemic index in diabetes. The American journal of clinical nutrition, 59 (3 SUPPL), 747S–752S.
  • Browning, J.D., and Horton, J.D., 2004. Molecular mediators of hepatic steatosis and liver injury. The Journal of clinical investigation, 114 (2), 147–152.
  • Caldwell, S.H., et al., 1999. Mitochondrial abnormalities in non-alcoholic steatohepatitis. Journal of hepatology, 31 (3), 430–434.
  • Camini, F.C., and Costa, D.C., 2020. Silymarin: not just another antioxidant. Journal of basic and clinical physiology and pharmacology, 31 (4), 1–12.
  • Carvalho, L.C.F., et al., 2021. Temporal effect of fructose supplementation at different concentrations on hepatic metabolism of wistar rats. Nutrición Hospitalaria, 38, 1089–1100.
  • Castro, M.C., et al., 2012. Apocynin administration prevents the changes induced by a fructose-rich diet on rat liver metabolism and the antioxidant system. Clinical Science (London, England : 1979), 123 (12), 681–692.
  • Chang, C-c., et al., 2002. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. Journal of Food and Drug Analysis, 10 (3), 178–182.
  • Chen, Q., et al., 2017. Effects of natural products on fructose-induced Nonalcoholic Fatty Liver Disease (NAFLD). Nutrients, 9 (2), 96.
  • Cheng, C.F., Ku, H.C., and Lin, H., 2018. Pgc-1α as a pivotal factor in lipid and metabolic regulation. International journal of molecular sciences, 19 (11), 3447–21.
  • Chen, H.L., et al., 2016. Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulating inflammation and the JAK2 signaling pathway. Nutrition and diabetes, 6 (12), e237.
  • Chrostek, L., et al., 2014. The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins. Clinical and experimental medicine, 14 (4), 417–421.
  • Delli Bovi, A.P., et al., 2021. Oxidative stress in non-alcoholic fatty liver disease. an updated mini review. Frontiers in medicine, 8, (February), 1–14.
  • Dias, B.V., et al., 2022. EPA/DHA and linseed oil have different effects on liver and adipose tissue in rats fed with a high-fat diet. Prostaglandins & Other Lipid Mediators, 159, 106622.
  • Esterbauer, H., Schaur, R.J., and Zollner, H., 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free radical biology & medicine, 11 (1), 81–128.
  • Folch, J., Stanley Lees, M., and Sloane, G.H., 1957. A simple method for the isolation and purification of total lipides from animal tissues*. Journal of biological chemistry, 55 (5), 999–1033.
  • Feng, D., et al., 2019. Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE-/- mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation. Nutrition and metabolism, 16, 79.
  • Gharbia, S., et al., 2018. Enhancement of silymarin anti-fibrotic effects by complexation with hydroxypropyl (HPBCD) and randomly methylated (RAMEB) β-cyclodextrins in a mouse model of liver fibrosis. Frontiers in pharmacology, 9 (AUG), 1–18.
  • Guo, Y., et al., 2016. Silymarin improved diet-induced liver damage and insulin resistance by decreasing inflammation in mice. Pharmaceutical biology, 54 (12), 2995–3000.
  • Hatazawa, Y., et al., 2015. Metabolomic analysis of the skeletal muscle mice overexpressing PGC-1α. PLoS one, 10 (6), e0129084.
  • Hughes, S.D., et al., 2014. The ketogenic diet component decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells. Journal of neurochemistry, 129 (3), 426–433.
  • Hunkeler, M., et al., 2018. Structural basis for regulation of human acetyl-CoA carboxylase. Nature, 558 (7710), 470–474.
  • Jones, J.E.C., et al., 2017. Inhibition of acetyl-CoA carboxylase 1 (ACC1) and 2 (ACC2) reduces proliferation and de novo lipogenesis of EGFRvIII human glioblastoma cells. PLoS one, 12 (1), e0169566.
  • Karise, I., et al., 2017. Liver and metformin: lessons of a fructose diet in mice. Biochimie open, 4, 19–30.
  • Khazim, K., et al., 2013. The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo. American journal of physiology - renal physiology, 305 (5), F691–F700.
  • Kheiripour, N., et al., 2019. Hepatoprotective effects of silymarin on liver injury via irisin upregulation and oxidative stress reduction in rats with type 2 diabetes. Iranian journal of medical sciences, 44 (2), 108–117.
  • Köksal, E., et al., 2009. In vitro antioxidant activity of silymarin. Journal of Enzyme Inhibition and Medicinal Chemistry, 24 (2), 395–405.
  • Krebs, H.A., 1970. Rate control of the tricarboxylic acid cycle. Advances in enzyme regulation, 8 (C), 335–353.
  • Kumar, S., and Pandey, A.K., 2013. Chemistry and biological activities of flavonoids : an overview. The scientific world journal, 2013, 1–16.
  • LAEMMLI, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature publishing nature, 227 (5259), 680–685.
  • Levene, A.P., and Goldin, R.D., 2010. Physiological hepatic nuclear vacuolation - how long does it persist? Histopathology, 56 (4), 426–429.
  • Levine, R.L., et al., 1994. Carbonyl assays for determination of oxidatively modified proteins. Methods in enzymology, 233 (C), 346–357.
  • Li, X., Wu, X., and Huang, L., 2009. Correlation between antioxidant activities and phenolic contents of radix Angelicae sinensis (Danggui). Molecules (Basel, Switzerland), 14 (12), 5349–5361.
  • Liu, S., and Manson, J.E., 2001. Dietary carbohydrates, physical inactivity, obesity, and the ‘metabolic syndrome’ as predictors of coronary heart disease. Current opinion in lipidology, 12 (4), 395–404.
  • Liu, Z., et al., 2014. Alanine aminotransferase-old biomarker and new concept: A review. International journal of medical sciences, 11 (9), 925–935.
  • Lovelace, E.S., et al., 2015. Silymarin suppresses cellular inflammation by inducing reparative stress signaling. Journal of natural products, 78 (8), 1990–2000.
  • LOWRY, O.H., et al., 1951. Protein measurement with the folin phenol reagent. The journal of biological chemistry, 193 (1), 265–275.
  • Machado-Junior, P.A., et al., 2020. Protective effects of quercetin on livers from mice exposed to long-term cigarette smoke. BioMed research international, 2020, 1–10.
  • Madan, K., et al., 2006. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). Journal of clinical gastroenterology, 40 (10), 930–935.
  • Mayes, P.A., 1993. Intermediary metabolism of fructose. American journal of clinical nutrition, 58 (5 Suppl), 754S–765S.
  • Mc Garry, J.D., and Foster, D.W., 1980. Regulation of hepatic fatty acid oxidation and ketone body production. Annual review of biochemistry, 49, 395–420.
  • Miranda, P.H.D.A., et al., 2018. Oral formulation of DPP-4 inhibitor plus quercetin improves metabolic homeostasis in type 1 diabetic rats. Scientific reports, 8 (1), 1–12.
  • Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of immunological methods, 65 (1–2), 55–63.
  • Ni, X., and Wang, H., 2016. Silymarin attenuated hepatic steatosis through regulation of lipid metabolism and oxidative stress in a mouse model of nonalcoholic fatty liver disease (NAFLD). American journal of translational research, 8 (2), 1073–1081.
  • Noureddin, M., Mato, J.M., and Lu, S.C., 2015. Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine. Experimental biology and medicine (Maywood, N.J.), 240 (6), 809–820.
  • Oliveira , et al., 2019. Metformin modulates innate immune inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish. Journal of hepatology, 176 (5), 139–148.
  • Oseini, A.M., and Sanyal, A.J., 2017. Therapies in non-alcoholic steatohepatitis (NASH). Liver international, 37 (October 2016), 97–103.
  • Pervez, M.A., et al., 2018. Effects of delta-tocotrienol supplementation on liver enzymes, inflammation, oxidative stress and hepatic steatosis in patients with nonalcoholic fatty liver disease. The Turkish Journal of Gastroenterology : The Official Journal of Turkish Society of Gastroenterology, 29 (2), 170–176.
  • Pinto, H.C., et al., 1996. Nonalcoholic steatohepatitis: clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Digestive diseases and sciences, 41 (1), 172–179.
  • RE, R., et al., 1999. Antioxidant activity applying an improved abts radical cation decolorization assay. Free radical biology & medicine, 26 (9–10), 1231–1237.
  • Reagan‐Shaw, S., Nihal, M., and Ahmad, N., 2008. Dose translation from animal to human studies revisited. FASEB journal : official publication of the federation of American societies for experimental biology, 22 (3), 659–661.
  • Reid, B.N., et al., 2008. Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis. The journal of biological chemistry, 283 (19), 13087–13099.
  • Repetto, G., Peso, A., and Zurita, J.L., 2008. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nature protocols, 3 (7), 1125–1131.
  • Rippe, J.M., and Angelopoulos, T.J., 2013. Sucrose, high-fructose corn syrup, and fructose, their metabolism and potential health effects : what do we really know ? Advances in nutrition 4 (2), 236–245.
  • Rufino, M. d S. M., et al., 2010. Bioactive compounds and antioxidant capacities of 18 non-traditional tropical fruits from Brazil. Food chemistry, 121 (4), 996–1002.
  • Rufino, M. d S. M., et al., 2007. Metodologia Científica : Determinação Da Atividade Antioxidante Total Em Frutas Pela Captura Do Radical Livre. Fortaleza, Brazil: EMBRAPA.
  • Serçe, A., et al., 2016. Assessment of the antioxidant activity of silybum marianum seed extract and its protective effect against DNA oxidation, protein damage and lipid peroxidation. Food technology and biotechnology, 54 (4), 455–461.
  • Sedlak, J., and Lindsay, R.H., 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Analytical biochemistry, 25 (1), 192–205.
  • Siu, P.M., et al., 2003. Citrate synthase expression and enzyme activity after endurance training in cardiac and skeletal muscles. Journal of applied physiology (Bethesda, Md. : 1985), 94 (2), 555–560.
  • Spahis, S., et al., 2017. Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis. Antioxidants & redox signaling, 26 (10), 519–541.
  • Sumida, Y., et al., 2013. Involvement of free radicals and oxidative stress in NAFLD/NASH. Free Radical Research, 47 (11), 869–880.
  • Sumida, Y., et al., 2019. 49 Hepatology research effect of luseogliflozin on hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease: a prospective. Hepatology research : the official journal of the Japan society of hepatology, 49 (1), 64–71.
  • Surai, P.F., 2015. Silymarin as a natural antioxidant: an overview of the current evidence and perspectives. Antioxidants (Basel, Switzerland), 4 (1), 204–247.
  • Towbin, H., Staehelint, T., and Gordon, J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the national academy of sciences of the United States of America, 19 (6), 527–529.
  • Tupe, R.S., Kemse, N.G., and Khaire, A.A., 2014. Evaluation of antioxidant potentials and total phenolic contents of selected Indian herbs powder extracts. International Food Research Journal, 20 (May), 1053–1063.
  • Wilkening, S., Stahl, F., and Bader, A., 2003. Hepg2 with regard to their biotransformation properties. Drug metabolism and disposition: the biological fate of chemicals, 31 (8), 1035–1042.
  • Wisdom, S.J., et al., 1991. Antioxidant Systems in normal pregnancy and in pregnancy-induced hypertension. American journal of obstetrics and gynecology, 165 (6), 1701–1704.
  • Younossi, Z.M., et al., 2016. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore, Md.), 64 (1), 73–84.
  • Yurtcu, E., Darcansoy Iseri, O., and Iffet Sahin, F., 2015. Effects of silymarin and silymarin-doxorubicin applications on telomerase activity of human hepatocellular carcinoma cell line HepG2. Journal of B.U.ON. : official Journal of the Balkan Union of Oncology, 20 (2), 555–561.
  • Yusuf, S., et al., 2014. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. The new England journal of medicine, 371 (9), 818–827.
  • Zahir, N.V., et al., 2018. Evaluation of silibinin effects on the viability of HepG2 (human hepatocellular liver carcinoma) and HUVEC (human umbilical vein endothelial) cell lines. Iranian journal of pharmaceutical research, 17 (September 2015), 261–267.
  • Zhu, S.Y., et al., 2018. Silybum marianum oil attenuates hepatic steatosis and oxidative stress in high fat diet-fed mice. Biomedicine & Pharmacotherapy = Biomedecine & pharmacotherapie, 100 (January), 191–197.
  • Zu, X., et al., 2013. Chemical Genetics Of Acetyl-CoA carboxylases. Molecules (Basel, Switzerland), 18 (2), 1704–1719.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.